August 17, 2018 9:41am
I maintain as a short-term trading vehicle as there is more historical upside to “eat” through!
Rebounding CRSP (+$2.94 or +6.25%), EDIT (+$0.87 or +2.99%) and NTLA (+$1.02 or +3.78%) are candidates;
.... after Wednesday’s CRSP (-$0.80 or -1.67%), EDIT (-$0.53 or -1.79%) and NTLA (-$0.92 or -3.30%)
Cas12 had been touted as the discovery of the century, but still comes with huge risks; Cas9 could right-size that potential!
Editas Medicine (EDIT) …
The stock's 50-day moving average of $33.29 is below its 200-day moving average of $35.33;
- Volume at the close was 542.8 K shares traded <3 month average = 1.007 M shares>;
- The 52 week high was $45.02 and the low is $17.35;
- Shares outstanding are 47.35 M and the float is 42.1 M;
-
52 week change +54.63%;
- Shares short (as of 7/12) of float is 12.32% or 5.56 M, up from June’s 5.14 M
CRISPR Therapeutics AG (CRSP) …
- The stock's 50-day moving average was $54.82 is above its 200-day moving average of $52.99;
- Volume at the close was 444.9 K shares traded <3 month average = 1.468 M shares>;
- The 52 week high was $73.90 and the low is $16.16;
- Shares outstanding are 47.59 M and the float is 25.81 M;
-
The 52-week change is +155.76%;
- Shares short (as of 6/14) of float is 11.65% or 3.45 M, up from May’s 2.81M
Intellia (NTLA) …
- The stock's 50-day moving average of $28.74 is above its 200-day moving average of $25.83;
- Volume at the close was 533.2 K <3 month average = 880.5 K shares>;
- Shares outstanding are 43.2 M and the float is 30.86;
- The 52 week range is $15.06 with a high is $35.99;
-
The 52 week change is +70.22%;
- Shares short of float (as of 7/12) is 17.1% or 6.85 M shares up from 6/14’s 5.14 M;
Gene “editors” have focused mostly on the ability to cut DNA; they should be paying attention to the potential of after effects!
Reiterating, “Would you bet your life and your current portfolio on a mouse model; it’s always a game of “truth or consequences”.
Reiterating, I’ve been seeing CRSP, EDIT and NTLA existing in the trading “sand box”!
Analyst coverage (August) recommendations:
- NTLA has 2 HOLDs, 2 BUYs and 2 Strong BUYs;
- CRSP has 1 Strong BUY, 2 BUYs and 3 HOLDs and
- EDIT has 4 Strong BUYs and 4 HOLDs …
Which makes me a contrarian as I say TRADE - SELL the ups and BUY the downs!
